scispace - formally typeset
J

Jens Raila

Researcher at University of Potsdam

Publications -  87
Citations -  2544

Jens Raila is an academic researcher from University of Potsdam. The author has contributed to research in topics: Retinol & Vitamin. The author has an hindex of 24, co-authored 86 publications receiving 2303 citations.

Papers
More filters
Journal ArticleDOI

Role of endocytosis in cellular uptake of sex steroids.

TL;DR: It is demonstrated that megalin, an endocytic receptor in reproductive tissues, acts as a pathway for cellular uptake of biologically active androgens and estrogens bound to sex hormone binding globulin.
Journal ArticleDOI

DPP-4 Inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy

TL;DR: DPP-4 inhibition on top of ARB treatment significantly reduced urinary albumin excretion and oxidative stress in diabetic eNOS knockout mice and may offer a new therapeutic approach for patients with diabetic nephropathy.
Journal ArticleDOI

Evidence That Kidney Function but Not Type 2 Diabetes Determines Retinol-Binding Protein 4 Serum Levels

TL;DR: Existing human data showing elevated RBP4 levels in type 2 diabetic patients may be the result of moderate renal insufficiency rather than support for the suggestion thatRBP4 links obesity to type 2 diabetes.
Journal ArticleDOI

Concentrations of carotenoids, retinol and α‐tocopherol in plasma and follicular fluid of women undergoing IVF

TL;DR: The variability in the concentration was much greater in follicular fluid obtained from women without reproductive success, which remains to be elucidated, if this is indicative of a disturbed sieving effect of the blood-follicle barrier with possibly negative consequences for oocyte maturation.
Journal ArticleDOI

Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients.

TL;DR: This study suggests that plasma RBP4 levels in type 2 diabetic patients are affected by incipient nephropathy, and further studies evaluating RBP 4 as a regulator of systemic insulin resistance and type 2 diabetes will need to take renal function into consideration.